Clinical Trial Update: Role of Metabolites in Nicotine Dependence (1) - 1 [Phase 2]

View source ↗

Summary

A Phase 2 trial update examining the role of metabolites in nicotine dependence for tobacco use disorder; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tobacco Use Disorder

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Tobacco Use Disorder | Phase 2 | Status: COMPLETED